Verified ComparisonLast updated: 17 April 2026
Ipamorelin vs Sermorelin
Ipamorelin targets the ghrelin receptor; sermorelin targets GHRH receptors. In research literature, they are frequently discussed as a synergistic pairing for dual GH-axis stimulation.
Ipamorelin
GH Secretagogue
4.2/ 5
A−
Sermorelin
GH Releasing
4.1/ 5
A−
Editor's note
These are mechanistically complementary; research often combines them rather than choosing one.
| Criterion | Ipamorelin | Sermorelin |
|---|---|---|
| Mechanism | GHS-R / ghrelin agonist | GHRH analog |
| GH release pattern | Direct GHS-R activation | GHRH-mediated pulsatile release |
| Often combined in research? | Yes — frequent pairing | Yes — frequent pairing |
| Half-life | Very short | Very short |
| Regulatory pathway (AU) | Research-only | Defined indication |
Frequently asked questions
Research literature suggests dual-pathway GH stimulation is more effective than either alone.
Want to read the full reviews?